These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 37620069)

  • 1. Synucleinopathies.
    Lamotte G; Singer W
    Handb Clin Neurol; 2023; 196():175-202. PubMed ID: 37620069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An overview on pure autonomic failure.
    Pavy-Le Traon A; Foubert-Samier A; Fabbri M
    Rev Neurol (Paris); 2024; 180(1-2):94-100. PubMed ID: 38129276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of cardiovascular autonomic failure in the differential diagnosis of α-synucleinopathies.
    Leys F; Wenning GK; Fanciulli A
    Neurol Sci; 2022 Jan; 43(1):187-198. PubMed ID: 34817726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in establishing fluid biomarkers for the diagnosis and differentiation of alpha-synucleinopathies - a mini review.
    Singer W
    Clin Auton Res; 2022 Aug; 32(4):291-297. PubMed ID: 35895157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synucleinopathies.
    Coon EA; Singer W
    Continuum (Minneap Minn); 2020 Feb; 26(1):72-92. PubMed ID: 31996623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synuclein-One study: skin biopsy detection of phosphorylated α-synuclein for diagnosis of synucleinopathies.
    Gibbons CH; Freeman R; Bellaire B; Adler CH; Moore D; Levine T
    Biomark Med; 2022 May; 16(7):499-509. PubMed ID: 35272481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different phenoconversion pathways in pure autonomic failure with versus without Lewy bodies.
    Goldstein DS; Isonaka R; Lamotte G; Kaufmann H
    Clin Auton Res; 2021 Dec; 31(6):677-684. PubMed ID: 34669076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early autonomic and cognitive dysfunction in PD, DLB and MSA: blurring the boundaries between α-synucleinopathies.
    Palermo G; Del Prete E; Bonuccelli U; Ceravolo R
    J Neurol; 2020 Dec; 267(12):3444-3456. PubMed ID: 32594302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unveiling autonomic failure in synucleinopathies: Significance in diagnosis and treatment.
    Clement G; Cavillon G; Vuillier F; Bouhaddi M; Béreau M
    Rev Neurol (Paris); 2024; 180(1-2):79-93. PubMed ID: 38216420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-synuclein Immunization Strategies for Synucleinopathies in Clinical Studies: A Biological Perspective.
    Knecht L; Folke J; Dodel R; Ross JA; Albus A
    Neurotherapeutics; 2022 Sep; 19(5):1489-1502. PubMed ID: 36083395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autonomic Dysfunction in the Synucleinopathies.
    Coon EA
    Semin Neurol; 2020 Oct; 40(5):492-501. PubMed ID: 32906169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. REM Sleep Behavior Disorder in Parkinson's Disease and Other Synucleinopathies.
    St Louis EK; Boeve AR; Boeve BF
    Mov Disord; 2017 May; 32(5):645-658. PubMed ID: 28513079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural history of pure autonomic failure: A United States prospective cohort.
    Kaufmann H; Norcliffe-Kaufmann L; Palma JA; Biaggioni I; Low PA; Singer W; Goldstein DS; Peltier AC; Shibao CA; Gibbons CH; Freeman R; Robertson D;
    Ann Neurol; 2017 Feb; 81(2):287-297. PubMed ID: 28093795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic approaches in Parkinson's disease and related disorders.
    Valera E; Masliah E
    J Neurochem; 2016 Oct; 139 Suppl 1(Suppl 1):346-352. PubMed ID: 26749150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin in synucleinopathies.
    Hsam O; Kohl Z
    Behav Brain Res; 2023 May; 445():114367. PubMed ID: 36863462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limelight on alpha-synuclein: pathological and mechanistic implications in neurodegeneration.
    Wales P; Pinho R; Lázaro DF; Outeiro TF
    J Parkinsons Dis; 2013; 3(4):415-59. PubMed ID: 24270242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prodromal α-Synucleinopathies.
    Chahine LM
    Continuum (Minneap Minn); 2022 Oct; 28(5):1268-1280. PubMed ID: 36222764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. α-Synuclein conformers reveal link to clinical heterogeneity of α-synucleinopathies.
    Schmitz M; Candelise N; Canaslan S; Altmeppen HC; Matschke J; Glatzel M; Younas N; Zafar S; Hermann P; Zerr I
    Transl Neurodegener; 2023 Mar; 12(1):12. PubMed ID: 36915212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pure autonomic failure: Predictors of conversion to clinical CNS involvement.
    Singer W; Berini SE; Sandroni P; Fealey RD; Coon EA; Suarez MD; Benarroch EE; Low PA
    Neurology; 2017 Mar; 88(12):1129-1136. PubMed ID: 28202694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival and Causes of Death Among People With Clinically Diagnosed Synucleinopathies With Parkinsonism: A Population-Based Study.
    Savica R; Grossardt BR; Bower JH; Ahlskog JE; Boeve BF; Graff-Radford J; Rocca WA; Mielke MM
    JAMA Neurol; 2017 Jul; 74(7):839-846. PubMed ID: 28505261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.